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Figure 1. Telomerase reverse transcriptase 
structure. The figure shows the catalytic 
subunit (TERT) bound to DNA with its RNA 
subunit (TERC).  
 
Figure 2. p53 and p16-pRb pathways lead to 
growth arrest by senescence. 
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Introduction to telomeres and telomerase_____________ 
T-loop: an structure that protects telomeres 
Human telomeres consist in TTAGGG repeats and, as chromosomes’ extremes, must be protected. 
When not, the cell self-recognizes telomeres as dsDNA breaks, and activates de DNA damage 
response (DDR). In consequence, it can form aberrant structures such as end-to-end fusions with 
other chromosomes. The T-loop develops this function by a nucleoprotein complex in which a ssDNA 
extreme inserts into the dsDNA, displacing the other chain. 
Telomeres get shorter with each replication 
Because of the end-replication problem, telomeres get shortened 27bp per year. The end replication 
problem is based in the fact that in each replication, there is a lead and a lagging strand. The lead 
strand is replicated until the end, but the lagging strand needs a primer from which get copied. When 
the replication fork arrives to the extreme, there is no space for a primer, and there always remains a 
gap. 
Telomerase maintains an stable telomere length 
Telomerase is a reverse transcriptase formed by two subunits: a catalytic subunit (TERT) and a RNA 
subunit (TERC). TERC acts as a template for the TERT, with a complementary sequence to TTAGGG, 
with the purpose to elongate telomeres and maintain their length.(Fig. 1). 
Aging_______________________________________________________ 
Aging is associated with gradual decreased organ and tissue functionality, that leads to age-related pathologies, such as 
cardiovascular diseases, diabetes type II, and osteoporosis. 
Risk factors of telomere shortening 
Obesity, smoking, alcohol consumption, and social and economical disadvantages drive to an increased telomere shortening. 
All these risk factors converge in the same mechanism to induce aging: ROS and inflammation. ROS and inflammation lead to 
a DNA damage accumulation. 
Mechanisms to induce aging 
Aging phenotype arise from several factors, such as ROS, inflammation, and factors that induce to DNA damage (genotoxic 
agents, DNA repair deficiencies, or telomere dysfunction). In fact, p53 activation simultaneously with DNA damage and 
mitochondrial dysfunction leads to decreased tissue function (Fig. 3). 
Aging theories_______________________________________________ 
DNA damage accumulation 
Accumulation of DNA lesions in stem cells decreases their functionality, leading to loss of tissue function with age. 
Telomere length as a biological clock 
This model describes aging as a result from a cellular program controlled by a biological clock such as telomere length. 
Telomere shortening increases through aging, triggering to senescence, which thereby induces to a loss of tissue functionality. 
 
Conclusions_________________________________________________ 
•Alcohol and tobacco consumption, obesity and social and economical disadvantages lead to 
an increase  in ROS and inflammation. 
•Several factors, such as ROS and inflammation, lead to p53 activation. 
•Telomere shortening and dysfunction, simultaneously with DNA damage, mitochondrial 
dysfunction and p53 activation leads to a loss in the post-mitotic cells, and stem cells function. 
Finally, this aspects trigger tissue loss of function. All these factors taken together result in the 
known phenotype of aging. 
•Lifestyle determines some of the environmental factors that lead to aging. 
A change in lifestyle to better alimentation, regular exercise and healthy habits will 
protect our telomeres from increased shortening, thus providing us better aging 
perspectives and an increased life span. 
Senescence______________________________________ 
Senescence is induced by telomere shortening 
When a cell performs enough replications, and its telomeres are eroded, it enters in senescence. 
However, there are much more ways of inducing senescence, such as: DNA damage, chromatin 
perturbation, oncogens and stress. 
Senescence is a tumor suppressor mechanism 
When a cell solds out its telomeres, it can form end-to-end fusions and other aberrant structures, 
leading to genome instability.  Genome instability establishes a potential capacity for the cell to lead 
to malignant transformation. 
Senescence is mediated by p53 and p16 pathways 
p53 pathway induces p21 activation, and pRb pathway is induced by p16 activation. Both p21 and 
p16 are cyclin dependent kinases inhibitors (CDKI), which arrest cell cycle.   
Both pathways induce pRb hipophosphorylation, thus preventing proliferative genes expression by 
E2F transcription factor (Fig. 2). 
Cancer__________________________________________ 
Skipping senescence leads to cancer 
p53 and pRb mediate growth arrest in senescence. Thus, p53 and pRb inactivation leads to 
senescence escape, which allows further replicative cycles, and provides a potential malignant 
capacity to the cell. 
Telomerase is expressed in cancerous cells 
Cancerous cells need a mechanism to maintain their telomere length stable and avoid the end 
replication problem. Thus, it has been seen telomerase expression in 90% of tumors, while the 
remaining 10% cells maintain their telomere length by alternative mechanisms, such as Alternative 
Lengthening of Telomeres (ALT). 
Anti-telomerase therapy 
Due to its paper in maintaining the viability of cancerous cells, it has been purposed the use of 
telomerase inhibitors as a treatment to cure cancer. However, telomerase expression is also found in 
stem and reproductive cells. Thus, anti-telomerase therapy has shown an obvious inconvenient that 
must be resolved. 
 
Figure 3. p53 activation, simultaneously with DNA damage and 
mitochondrial dysfunction  leads to decreased tissue function, which is 
the base of aging. 
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